Mink Therapeutics Inc (INKT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	97.43% 0.000348	0.0135	0.0396	0.078	0.0384
Operating Expenses	49.32% 4.0527	2.7142	2.5423	1.9626	3.1094
Interest Income/Expense	6.90% -0.027	-0.029	-	-	-
Benefits Costs and Expenses	100.00% -	2.7802	2.5027	-	-
Costs And Expenses	45.77% 4.0527	2.7802	2.5027	1.9626	3.1094
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	50.05% -4.0524	-2.7007	-2.5027	-1.8846	-3.0711
Net Interest Income/Expense	97.43% 0.000348	0.0135	0.0396	0.078	0.0384
Interest And Devidend Income	72.14% -0.0267	-0.0155	-	-	-
Income/Loss From Continuing Operations Before Tax	100.01% 0.000348	-2.7667	-2.4631	0.078	-2.7018
Income/Loss From Continuing Operations After Tax	53.17% -4.2378	-2.7667	-2.4631	-1.8066	-2.7018
Net Income/Loss	53.17% -4.2378	-2.7667	-2.4631	-1.8066	-2.7018
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.43% 3.982	3.965	-33.34	39.53	37.14
Diluted Average Shares	0.43% 3.982	3.965	-33.34	39.53	37.14
Basic Earnings Per Share	51.43% -1.06	-0.70	-2.64	-0.05	-0.07
Diluted Earnings Per Share	51.43% -1.06	-0.70	-2.64	-0.05	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.84

1.45%

GMAB

$28.76

0.17%

INCY

$102.92

1.33%

BNTX

$104.83

0.84%

ONC

$309.19

0.86%

INSM

$182.77

1.86%